{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:06:05Z","timestamp":1780549565451,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-026-05586-y","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:31:50Z","timestamp":1780547510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Navigating PI-RADS v2.1 in clinical practice: pitfalls, variability, and the supportive role of AI"],"prefix":"10.1007","author":[{"given":"Serdar","family":"Aslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve Nur","family":"Tasdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Kyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Arita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"issue":"3","key":"5586_CR1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, et al. (2019) Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 76(3):340\u2013351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033","journal-title":"Eur Urol"},{"issue":"2","key":"5586_CR2","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1148\/radiol.2019182946","volume":"292","author":"AR Padhani","year":"2019","unstructured":"Padhani AR, Barentsz J, Weinreb JC, et al. (2019) PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway. Radiology 292(2):464\u2013474. https:\/\/doi.org\/10.1148\/radiol.2019182946","journal-title":"Radiology"},{"issue":"10071","key":"5586_CR3","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, et al. (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815\u2013822. https:\/\/doi.org\/10.1016\/S0140-6736(16)32401-1","journal-title":"Lancet"},{"issue":"19","key":"5586_CR4","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M, et al; PRECISION Study Group Collaborators (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378(19):1767\u20131777. https:\/\/doi.org\/10.1056\/NEJMoa1801993","journal-title":"N Engl J Med"},{"issue":"2","key":"5586_CR5","doi-asserted-by":"publisher","first-page":"e233337","DOI":"10.1148\/radiol.233337","volume":"312","author":"B Oerther","year":"2024","unstructured":"Oerther B, Nedelcu A, Engel H, et al. (2024) Update on PI-RADS Version 2.1 Diagnostic Performance Benchmarks for Prostate MRI: Systematic Review and Meta-Analysis. Radiology 312(2):e233337. https:\/\/doi.org\/10.1148\/radiol.233337","journal-title":"Radiology"},{"issue":"1","key":"5586_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1148\/radiol.2020190646","volume":"296","author":"AC Westphalen","year":"2020","unstructured":"Westphalen AC, McCulloch CE, Anaokar JM, et al. (2020) Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology 296(1):76\u201384. https:\/\/doi.org\/10.1148\/radiol.2020190646","journal-title":"Radiology"},{"issue":"4","key":"5586_CR7","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/bju.16452","volume":"134","author":"M Taya","year":"2024","unstructured":"Taya M, Behr SC, Westphalen AC (2024) Perspectives on technology: Prostate Imaging-Reporting and Data System (PI-RADS) interobserver variability. BJU Int 134(4):510\u2013518. https:\/\/doi.org\/10.1111\/bju.16452","journal-title":"BJU Int"},{"issue":"2","key":"5586_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.euo.2020.02.005","volume":"3","author":"A Stabile","year":"2020","unstructured":"Stabile A, Giganti F, Kasivisvanathan V, et al. (2020) Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review. Eur Urol Oncol 3(2):145\u2013167. https:\/\/doi.org\/10.1016\/j.euo.2020.02.005","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"5586_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2214\/AJR.20.24495","volume":"216","author":"AS Purysko","year":"2021","unstructured":"Purysko AS, Baroni RH, Giganti F, et al. (2021) PI-RADS Version 2.1: A Critical Review, From the AJR Special Series on Radiology Reporting and Data Systems. AJR Am J Roentgenol 216(1):20\u201332. https:\/\/doi.org\/10.2214\/AJR.20.24495","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"5586_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2214\/AJR.20.24199","volume":"217","author":"R Bhayana","year":"2021","unstructured":"Bhayana R, O\u2019Shea A, Anderson MA, et al. (2021) PI-RADS Versions 2 and 2.1: Interobserver Agreement and Diagnostic Performance in Peripheral and Transition Zone Lesions Among Six Radiologists. AJR Am J Roentgenol 217(1):141\u2013151. https:\/\/doi.org\/10.2214\/AJR.20.24199","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"5586_CR11","doi-asserted-by":"publisher","first-page":"e2330611","DOI":"10.2214\/AJR.23.30611","volume":"222","author":"ET de Oliveira Correia","year":"2024","unstructured":"de Oliveira Correia ET, Purysko AS, et al. (2024) PI-RADS Upgrading Rules: Impact on Prostate Cancer Detection and Biopsy Avoidance of MRI-Directed Diagnostic Pathways. AJR Am J Roentgenol 222(5):e2330611. https:\/\/doi.org\/10.2214\/AJR.23.30611","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"5586_CR12","doi-asserted-by":"publisher","first-page":"7068","DOI":"10.1007\/s00330-024-10795-4","volume":"34","author":"M de Rooij","year":"2024","unstructured":"de Rooij M, Allen C, Twilt JJ, et al. (2024) PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI. Eur Radiol 34(11):7068\u20137079. https:\/\/doi.org\/10.1007\/s00330-024-10795-4","journal-title":"Eur Radiol"},{"issue":"1","key":"5586_CR13","doi-asserted-by":"publisher","first-page":"e240140","DOI":"10.1148\/radiol.240140","volume":"315","author":"B Turkbey","year":"2025","unstructured":"Turkbey B, Huisman H, Fedorov A, et al. (2025) Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0. Radiology 315(1):e240140. https:\/\/doi.org\/10.1148\/radiol.240140","journal-title":"Radiology"},{"issue":"7","key":"5586_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S1470-2045(24)00220-1","volume":"25","author":"A Saha","year":"2024","unstructured":"Saha A, Bosma JS, Twilt JJ, et al; PI-CAI consortium (2024) Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study. Lancet Oncol 25(7):879\u2013887. https:\/\/doi.org\/10.1016\/S1470-2045(24)00220-1","journal-title":"Lancet Oncol"},{"key":"5586_CR15","doi-asserted-by":"publisher","first-page":"11583","DOI":"10.1038\/s41467-025-66593-z","volume":"16","author":"H Wu","year":"2025","unstructured":"Wu H, Liu F, Yang Q, et al. (2025) Automated MRI system for clinically significant prostate cancer detection development validation and real-world implementation. Nat Commun 16:11583. https:\/\/doi.org\/10.1038\/s41467-025-66593-z","journal-title":"Nat Commun"},{"issue":"6","key":"5586_CR16","doi-asserted-by":"publisher","first-page":"e2515672","DOI":"10.1001\/jamanetworkopen.2025.15672","volume":"8","author":"JJ Twilt","year":"2025","unstructured":"Twilt JJ, Saha A, Bosma JS, et al. (2025) AI-Assisted vs Unassisted Identification of Prostate Cancer in Magnetic Resonance Images. JAMA Netw Open 8(6):e2515672. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.15672","journal-title":"JAMA Netw Open"},{"issue":"9","key":"5586_CR17","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1007\/s00261-024-04273-0","volume":"49","author":"SY Park","year":"2024","unstructured":"Park SY, Woo S, Park KJ, Westphalen AC. (2024) A pictorial essay of PI-RADS pearls and pitfalls: toward less ambiguity and better practice. Abdom Radiol (NY) 49(9):3190\u20133205. https:\/\/doi.org\/10.1007\/s00261-024-04273-0","journal-title":"Abdom Radiol (NY)"},{"issue":"13","key":"5586_CR18","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/jama.2025.13722","volume":"334","author":"ABCD Ng","year":"2025","unstructured":"Ng ABCD, Asif A, Agarwal R, et al (2025) Biparametric vs multiparametric MRI for prostate cancer diagnosis: the PRIME diagnostic clinical trial. JAMA 334(13):1170\u20131179. https:\/\/doi.org\/10.1001\/jama.2025.13722","journal-title":"JAMA"},{"issue":"4","key":"5586_CR19","doi-asserted-by":"publisher","first-page":"792","DOI":"10.2214\/AJR.19.22072","volume":"214","author":"SY Park","year":"2020","unstructured":"Park SY, Park BK, Kwon GY (2020) Diagnostic Performance of Mass Enhancement on Dynamic Contrast-Enhanced MRI for Predicting Clinically Significant Peripheral Zone Prostate Cancer. AJR Am J Roentgenol 214(4):792\u2013799. https:\/\/doi.org\/10.2214\/AJR.19.22072","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"5586_CR20","doi-asserted-by":"publisher","first-page":"W33-W37","DOI":"10.2214\/AJR.09.3004","volume":"194","author":"CK Kim","year":"2010","unstructured":"Kim CK, Park BK, Kim B (2010) High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s\/mm2. AJR Am J Roentgenol 194(1):W33-W37. https:\/\/doi.org\/10.2214\/AJR.09.3004","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"5586_CR21","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1007\/s00330-025-11618-w","volume":"35","author":"G Agrotis","year":"2025","unstructured":"Agrotis G, Pooch EP, Marsitopoulos K, et al (2025) Detection rates for prostate cancer using PI-RADS 2.1 upgrading rules in transition zone lesions align with risk assessment categories: a systematic review and meta-analysis. Eur Radiol 35(10):6454\u20136465. https:\/\/doi.org\/10.1007\/s00330-025-11618-w","journal-title":"Eur Radiol"},{"issue":"4","key":"5586_CR22","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2214\/AJR.19.22653","volume":"215","author":"N Shin","year":"2020","unstructured":"Shin N, Park SY (2020) Postoperative Biochemical Failure in Patients With PI-RADS Category 4 or 5 Prostate Cancers: Risk Stratification According to Zonal Location of an Index Lesion. AJR Am J Roentgenol 215(4):913\u2013919. https:\/\/doi.org\/10.2214\/AJR.19.22653","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"5586_CR23","doi-asserted-by":"publisher","first-page":"W92-W100","DOI":"10.2214\/AJR.16.16876","volume":"208","author":"AB Rosenkrantz","year":"2017","unstructured":"Rosenkrantz AB, Ayoola A, Hoffman D, Khasgiwala A, Prabhu V, Smereka P, Somberg M, Taneja SS. (2017) The Learning Curve in Prostate MRI Interpretation: Self-Directed Learning Versus Continual Reader Feedback. AJR Am J Roentgenol 208(3):W92-W100. https:\/\/doi.org\/10.2214\/AJR.16.16876","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"5586_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4081\/aiua.2021.2.139","volume":"93","author":"P Pepe","year":"2021","unstructured":"Pepe P, Candiano G, Pepe L, et al. (2021) mpMRI PI-RADS score 3 lesions diagnosed by reference vs affiliated radiological centers: our experience in 950 cases. Arch Ital Urol Androl 93(2):139\u2013142. https:\/\/doi.org\/10.4081\/aiua.2021.2.139","journal-title":"Arch Ital Urol Androl"},{"issue":"3","key":"5586_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.eururo.2022.01.008","volume":"82","author":"WG Brisbane","year":"2022","unstructured":"Brisbane WG, Priester AM, Ballon J, et al. (2022) Targeted prostate biopsy: umbra, penumbra, and value of perilesional sampling. Eur Urol 82(3):303\u2013310. https:\/\/doi.org\/10.1016\/j.eururo.2022.01.008","journal-title":"Eur Urol"},{"issue":"12","key":"5586_CR26","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1007\/s00261-020-02547-x","volume":"45","author":"IG Schoots","year":"2020","unstructured":"Schoots IG, Padhani AR. (2020) Delivering Clinical impacts of the MRI diagnostic pathway in prostate cancer diagnosis. Abdom Radiol (NY) 45(12):4012\u20134022. https:\/\/doi.org\/10.1007\/s00261-020-02547-x","journal-title":"Abdom Radiol (NY)"},{"key":"5586_CR27","unstructured":"European Association of Urology (2026) EAU Guidelines on Prostate Cancer \u2013 Diagnostic Evaluation. Available at: https:\/\/uroweb.org\/guidelines\/prostate-cancer\/chapter\/diagnostic-evaluation"},{"issue":"1","key":"5586_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41391-024-00872-6","volume":"28","author":"G Mjaess","year":"2025","unstructured":"Mjaess G, Haddad L, Jabbour T, et al. (2025) Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions. Prostate Cancer Prostatic Dis 28(1):173\u2013179. https:\/\/doi.org\/10.1038\/s41391-024-00872-6","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5586_CR29","doi-asserted-by":"publisher","first-page":"32830","DOI":"10.1038\/s41598-025-18336-9","volume":"15","author":"C Wang","year":"2025","unstructured":"Wang C, Han J, Zhu W, et al. (2025) A nomogram using transition zone PSA density for detecting clinically significant prostate cancer in PI-RADS 3 lesions. Sci Rep 15:32830. https:\/\/doi.org\/10.1038\/s41598-025-18336-9","journal-title":"Sci Rep"},{"issue":"11","key":"5586_CR30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.urolonc.2024.05.025","volume":"42","author":"T Ajami","year":"2024","unstructured":"Ajami T, Han S, Porto JG, et al. (2024) Molecular and diffusion features for identification of clinically significant prostate cancer in PI-RADS 3 lesions. Urol Oncol 42(11):370.e9-370.e14. https:\/\/doi.org\/10.1016\/j.urolonc.2024.05.025","journal-title":"Urol Oncol"},{"issue":"4","key":"5586_CR31","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/jmri.29268","volume":"60","author":"MJ Kim","year":"2024","unstructured":"Kim MJ, Park JJ, Kang KA, Park SY, Kim CK. (2024) Utility of Prostate Health Index Density for Biopsy Strategy in Biopsy-Na\u00efve Patients With PI-RADS v2.1 Category 3 Lesions. J Magn Reson Imaging. 60(4):1628\u20131636. https:\/\/doi.org\/10.1002\/jmri.29268.","journal-title":"J Magn Reson Imaging."},{"issue":"6","key":"5586_CR32","doi-asserted-by":"publisher","first-page":"e684-e687","DOI":"10.1016\/j.clgc.2020.04.001","volume":"18","author":"P Pepe","year":"2020","unstructured":"Pepe P, Pennisi M. (2020) Negative biopsy histology in men with PI-RADS score 5 in daily clinical practice: incidence of granulomatous prostatitis. Clin Genitourin Cancer 18(6):e684-e687. https:\/\/doi.org\/10.1016\/j.clgc.2020.04.001","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"5586_CR33","doi-asserted-by":"publisher","first-page":"12358","DOI":"10.4081\/aiua.2024.12358","volume":"96","author":"P Pepe","year":"2024","unstructured":"Pepe P, Pepe L, Pennisi M. (2024) Negative biopsy histology in men with PI-RADS score 5: Is it useful PSMA PET\/CT evaluation? Arch Ital Urol Androl 96(2):12358. https:\/\/doi.org\/10.4081\/aiua.2024.12358","journal-title":"Arch Ital Urol Androl"},{"issue":"5","key":"5586_CR34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.euo.2022.06.007","volume":"5","author":"S Kotamarti","year":"2022","unstructured":"Kotamarti S, Gupta RT, Wang B, et al. (2022) Reconciling discordance between prostate biopsy histology and magnetic resonance imaging suspicion \u2013 implementation of a quality improvement protocol of imaging re-review and reverse-fusion target analysis. Eur Urol Oncol 5(5):483\u2013493. https:\/\/doi.org\/10.1016\/j.euo.2022.06.007","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"5586_CR35","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/JU.0000000000001424","volume":"205","author":"X Meng","year":"2021","unstructured":"Meng X, Chao B, Chen F, et al. (2021) Followup of men with PI-RADS\u2122 4 or 5 abnormality on prostate magnetic resonance imaging and nonmalignant pathological findings on initial targeted prostate biopsy. J Urol 205(3):748\u2013754. https:\/\/doi.org\/10.1097\/JU.0000000000001424","journal-title":"J Urol"},{"issue":"5","key":"5586_CR36","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/RLU.0000000000006309","volume":"51","author":"FA Mourato","year":"2026","unstructured":"Mourato FA, Schmitt LG, Mariussi M, et al. (2026) The PRIMARY scoring system on PSMA PET for clinically significant prostate cancer detection: a systematic review and meta-analysis. Clin Nucl Med 51(5):406\u2013415. https:\/\/doi.org\/10.1097\/RLU.0000000000006309","journal-title":"Clin Nucl Med"},{"issue":"3","key":"5586_CR37","doi-asserted-by":"publisher","first-page":"e250701","DOI":"10.1148\/radiol.250701","volume":"317","author":"S Woo","year":"2025","unstructured":"Woo S, Masci B, Rowe SP, et al. (2025) Navigating the scoring systems and interpretation frameworks of prostate-specific membrane antigen PET. Radiology 317(3):e250701. https:\/\/doi.org\/10.1148\/radiol.250701","journal-title":"Radiology"},{"issue":"2","key":"5586_CR38","doi-asserted-by":"publisher","first-page":"13746","DOI":"10.4081\/aiua.2025.13746","volume":"97","author":"P Pepe","year":"2025","unstructured":"Pepe P, Pepe L, Cignoli D, et al. (2025) PSMA PET\/CT in the diagnosis of prostate cancer: why and when? Arch Ital Urol Androl 97(2):13746. https:\/\/doi.org\/10.4081\/aiua.2025.13746","journal-title":"Arch Ital Urol Androl"},{"key":"5586_CR39","doi-asserted-by":"publisher","unstructured":"Shojaei S, Yakar D, Vellinga N, Bozgo V, Kwee T, Huisman H, Mifsud Bonnici JP. (2026) The AI Act and the MDR post-market requirements for semiautonomous AI SaMD: a radiology case study in prostate cancer. Abdom Radiol (NY). Epub ahead of print. https:\/\/doi.org\/10.1007\/s00261-026-05434-z","DOI":"10.1007\/s00261-026-05434-z"},{"key":"5586_CR40","doi-asserted-by":"publisher","unstructured":"Nakai H, Froemming AT, Kawashima A, et al. (2025) Bias in deep learning-based image quality assessments of T2-weighted imaging in prostate MRI. Abdom Radiol (NY). Epub ahead of print. https:\/\/doi.org\/10.1007\/s00261-025-05163-9","DOI":"10.1007\/s00261-025-05163-9"},{"issue":"4","key":"5586_CR41","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ajur.2024.12.001","volume":"12","author":"Y Arita","year":"2025","unstructured":"Arita Y, Roest C, Kwee TC, et al. (2025) Advancements in artificial intelligence for prostate cancer: Optimizing diagnosis, treatment, and prognostic assessment. Asian J Urol 12(4):434\u2013444. https:\/\/doi.org\/10.1016\/j.ajur.2024.12.001","journal-title":"Asian J Urol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05586-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05586-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05586-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:32:04Z","timestamp":1780547524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-026-05586-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":41,"alternative-id":["5586"],"URL":"https:\/\/doi.org\/10.1007\/s00261-026-05586-y","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Y.A. serves as a Guest Editor for this Special Collection. To avoid any potential conflict of interest, Y.A. was not involved in the editorial processing or the decision-making process for this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}